Opens in a new tab

Dr. Liu Fenghua

Chinese name: 刘风华
Chief Physician, Doctoral Supervisor, Vice President . Reproductive Medicine & Infertility
Dr. Liu Fenghua is Vice President of Guangdong Women and Children Hospital, academic leader of reproductive medicine and Director of its Reproductive Center. A doctoral supervisor, she chairs the Guangdong Reproductive Medicine Society and specializes in infertility, individualized ovulation induction and assisted reproductive technology including IVF.

Private & confidential

No obligation

Coordinated end-to-end by Orisene

30+
Years in obstetrics and reproductive medicine
109
Peer-reviewed papers as first or corresponding author
about 60%
IVF/ICSI clinical pregnancy rate

  • The Physician

About Dr. Liu Fenghua

Dr. Liu Fenghua is Vice President of Guangdong Women and Children Hospital, academic leader of reproductive medicine and Director of the hospital's Reproductive Center. A chief physician and doctoral supervisor, she chairs the Guangdong Medical Association Reproductive Medicine Branch and specializes in infertility, reproductive endocrine disorders, endometriosis and recurrent miscarriage. She is an expert in individualized ovulation induction and assisted reproductive technology including IVF. She took part in a landmark multicenter trial on preimplantation genetic testing published in the New England Journal of Medicine and participates in national monitoring and evaluation of assisted reproductive technology.
1、Vice President of Guangdong Women and Children Hospital and academic leader of reproductive medicine
2、Director of the hospital’s Reproductive Center
3、Chair of the Guangdong Medical Association Reproductive Medicine Branch
4、Expert in individualized ovulation induction and assisted reproductive technology including IVF
5、Winner of the Guangdong May 1st Labor Medal and the Lingnan Famous Doctor title
6、Participant in national monitoring and evaluation of assisted reproductive technology

Dr. Liu Fenghua ’s Three Key Areas of Expertise

Three areas of focused expertise, each supported by a deep subspecialty team, high case volumes and an English-speaking care pathway coordinated by Orisene.

Infertility

As a leading reproductive medicine specialist, she evaluates and treats female infertility caused by ovulation disorders, tubal factors, endometriosis and endocrine problems, designing personalized treatment plans that give couples the best possible chance of conception and a healthy pregnancy and live birth.

Assisted reproductive technology

She performs and supervises in vitro fertilization, intracytoplasmic sperm injection and embryo transfer, applying individualized stimulation protocols, advanced laboratory techniques and careful embryo selection to maximize pregnancy and live birth rates for couples undergoing fertility treatment with complex reproductive needs.

Endometriosis and recurrent miscarriage

She manages endometriosis and recurrent pregnancy loss through medical and surgical treatment and reproductive immunology support, improving fertility, relieving pain and helping women achieve and maintain a successful pregnancy after previous losses through individualized, personalized long-term care and close clinical monitoring.

More: polycystic ovary syndrome——ovulation induction and metabolic management; ovulation disorders——individualized stimulation protocols; male factor infertility——semen assessment and treatment; reproductive preservation——fertility counselling and preservation

  • Clinical Practice & Publications

Selected cases, research & publications

Representative work drawn from documented clinical treatments, publicly indexed literature, and hospital project records, reflecting the depth of this physician's hands-on expertise and academic rigor.
1. Oocyte Vitrification and Frozen-Egg Live Birth Program
At Guangdong Women and Children Hospital, Dr. Liu Fenghua’s team has applied oocyte vitrification for years, achieving a post-thaw clinical pregnancy rate of about 60 percent. The program supports women facing fertility-threatening treatment, including patients seeking egg freezing before chemotherapy or surgery, and has helped many couples achieve a healthy live birth through frozen-egg IVF.
2. Landmark Clinical Cases in Genetic and Multiple Pregnancy Care
Dr. Liu Fenghua’s center performed China’s first fetal reduction for octuplets and multiple complex intrauterine-plus-ectopic pregnancy reductions. Using MaReCs technology, the team welcomed the province’s first baby free of a balanced translocation, offering carriers of chromosomal rearrangement a path to a healthy, genetically balanced child through IVF and preimplantation testing.
3. Enabling PGT-A on Conventional IVF Frozen Embryos (qPCT Study)
Dr. Liu Fenghua led an evidence-based study published in Reproductive BioMedicine Online on quantitative parental contamination testing (qPCT) for preimplantation genetic testing. Analyzing 120 vitrified blastocysts from conventional IVF cycles, the team found maternal contamination in only 0.83 percent of samples and showed PGT-A is applicable to routinely fertilized frozen embryos, improving IVF outcomes.
4. Optimizing Ovulation Induction: PPOS versus GnRH Antagonist
As corresponding author, Dr. Liu Fenghua compared progestin-primed ovarian stimulation (PPOS) with the GnRH antagonist protocol, evaluating cumulative live birth rates across different patient populations. Published in Frontiers in Endocrinology, the large multicenter analysis of 865 patients helps clinicians choose the most effective and safe ovulation induction strategy for IVF and infertility treatment.
5. Fertility Preservation for Cancer and High-Risk Patients
Dr. Liu Fenghua promotes a policy-technology-society model to protect fertility. Her hospital expanded fertility preservation from cancer patients to those with benign conditions that threaten ovarian function, such as autoimmune disease requiring long-term treatment. The program offers oocyte and embryo freezing, helping patients pursue pregnancy after medical treatment or before gonadotoxic therapy.
6. Real-World Evidence and Accessible Reproductive Care
Dr. Liu Fenghua advocates real-world evidence (RWE) to evaluate medication safety during pregnancy and assisted reproduction, where traditional randomized trials are limited. Through the national Cloud Maternal and Child project, her center brings fertility preservation technology to primary hospitals, so patients with infertility and recurrent miscarriage receive provincial-level reproductive care closer to home.
  • Affiliated Hospital

Where Dr. Liu Fenghua practices

Guangzhou

Guangdong Women and Children Hospital

Chinese name: 广东省妇幼保健院
Guangdong Maternal and Child Health Hospital, a Grade-A tertiary institution founded in 1944 and the province's maternal-child technical guidance center, operates four campuses with 1,255 licensed beds, 4 national key specialties (including neonatology and obstetrics) and 2668 qualified staff.
Since 1944
82 years of women & child care
1,255
Licensed beds
4
National key specialties
695
Licensed beds
View Hospital Profile
Appointments with this physician are booked through official hospital channels only, coordinated end-to-end by Orisene.
  • WHY INTERNATIONAL PATIENTS CHOOSE CHINA

Why patients travel to China for treatment

Six reasons international patients now put China on their shortlist — from internationally aligned clinical capability to the policy channels that make treatment here genuinely reachable.

Clinical capability at international standard

Chinese hospitals deliver internationally aligned protocols, performing vast volumes of advanced robotic, minimally invasive, and complex transplant surgeries annually. This massive clinical data and highly specialized workforce ensure world-class outcomes, even for rare and complex cases.

Diagnostics and treatment in days, not months

A full medical workup that typically means months of waiting elsewhere is completed in China within 48–72 hours. Imaging, labs, and multidisciplinary consultations are integrated into a single visit, allowing treatment to commence immediately.

Transparent, itemised pricing

Chinese healthcare offers legally binding, itemised cost estimates before treatment begins, eliminating hidden fees or surprise billing. Due to national centralized procurement, total expenses remain 40–70% lower than comparable care in Western Europe or North America.

Policy channels that open the door

China facilitates access through 240-hour visa-free transit and dedicated medical visa routes. Policies like the Greater Bay Area drug pathway and Boao Lecheng’s pilot zone allow designated hospitals to administer innovative therapies not yet globally approved.
  • International Patient Guide

Consulting this physician, step by step

From the first message to the follow-up after you fly home, one coordinator, no paperwork on your side.
01
Day 0
  • Share your story
    A private consultation with an Orisene advisor, by message, phone or video. Send medical records in any language. Nothing is shared with the hospital yet.
02
Days 1–3
  • Records review & matching
    Orisene translates and presents your case to the right specialist. The hospital returns a tailored care plan, with costs itemised once that plan is confirmed.
03
Days 3–7
  • Your consultation
    Appointments are booked through official hospital channels only. Your navigator accompanies every visit with real-time interpretation, so you can focus on one thing: being cared for.
04
After you fly home
  • Reports & follow-up
    Translated reports and prescriptions delivered within days, remote follow-up coordination with your physicians at home, and a standing line to your navigator.
Orisene offers English and multilingual services, a professional medical interpreter at every consultation, plus translation of your records, reports and prescriptions.

Ready to plan your consultation with Dr. Liu Fenghua?

Send your records in any language. An Orisene advisor will reply within 2 hours, present your case to the right specialist, and return a tailored care plan with itemised costs, before anything is booked. Simple. Private. Efficient.
Contact

Confidential, permanently

Independent — no hospital commission

We never handle medical fees

Information Sources

This physician profile is compiled by the Orisene team from publicly available online sources and verified at the time of publication. Details may change, and physician availability is confirmed at the time of booking.

Disclaimer: This information is for general educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider for personal medical guidance.

Mention of any specific product, brand, or manufacturer is for informational purposes only and does not constitute an endorsement or recommendation by Dr. Liu Fenghua.